ARCHER: Amortized cross-specimen pose estimation for cryo-electron microscopy
Abstract
Single-particle cryo-electron microscopy (cryo-EM) pose estimation is traditionally solved anew for each dataset, where iterative refinement is done from scratch while the estimator learns to store the molecule in its weights. In this work, we show that pose inference is a generalizable, specimen-agnostic operation when conditioned explicitly on a reference volume. We introduce ARCHER, an amortized contrastive classifier that models the pose posterior over a discrete rotation grid. Trained acros...
Description / Details
Single-particle cryo-electron microscopy (cryo-EM) pose estimation is traditionally solved anew for each dataset, where iterative refinement is done from scratch while the estimator learns to store the molecule in its weights. In this work, we show that pose inference is a generalizable, specimen-agnostic operation when conditioned explicitly on a reference volume. We introduce ARCHER, an amortized contrastive classifier that models the pose posterior over a discrete rotation grid. Trained across a variety of protein structures, it operates zero-shot without retraining per structure. This transferability is grounded in Fourier-space information mechanics, where all specimen dependence is captured by the reference structure's power spectrum and spatial extent. ARCHER achieves a median angular error of 5.0° on 100 held-out test structures and 2.5° on experimental particles, matching dedicated estimators within 0.16 Å in 3D reconstruction. Crucially, downstream conformational signal is preserved. The leading conformational coordinate correlates at 0.97 with deposited benchmarks, faithfully reconstructing free-energy basins and mobile domains. These results overall demonstrate that cryo-EM pose estimation can be generalized across different structures.
Source: arXiv:2608.22029v1 - http://arxiv.org/abs/2608.22029v1 PDF: https://arxiv.org/pdf/2608.22029v1 Original Link: http://arxiv.org/abs/2608.22029v1
Please sign in to join the discussion.
No comments yet. Be the first to share your thoughts!
Aug 25, 2026
Pharmaceutical Research
Biochemistry
0